Normalization method for a chronically implanted optical sensor

• US 7,512,431 B2
• Filed: 09/13/2005
• Issued: 03/31/2009
• Est. Priority Date: 09/13/2005
• Status: Expired due to Fees

• Current Assignee: Medtronic Incorporated (Medtronic Plc)
• Original Assignee: Medtronic Incorporated (Medtronic Plc)
• Inventors: Roberts, Jonathan P.
• Primary Examiner(s): Winakur; Eric F
• Assistant Examiner(s): Berhanu; Etsub D
• Application Number:
  US11/225,591
• Publication Number:
  US 20070060811A1
• Time in Patent Office: 1,295 Days
• Field of Search: 600/323, 600/325, 600/327, 600/332, 600/339, 600/341
• US Class Current: 600/332
• CPC Class Codes: A61B 5/1459 invasive, e.g. introduced into the body by a catheter A61B5/1464 takes precedence

Abstract

A system and method are provided for estimating blood oxygen saturation independent of optical sensor encapsulation due to placement in blood, where the blood includes a blood flow characteristic of: a relatively low, a stasis, a stagnant value. The method includes determining tissue overgrowth correction factor that includes optical properties of the tissue that cause scattering of the emitted light to a detector and relative amplitudes of the emitted light wavelengths. A corrected time interval measured for infrared light is based on an infrared signal and a corrected time interval for red light is determined by subtracting red light signal due to presence of tissue overgrowth. The red light signal due to tissue overgrowth is proportional to total infrared signal less nominal infrared signal. Oxygen saturation is estimated based on standard calibration factors and the ratio of the corrected infrared time interval and the corrected red time interval.

Claims

1. A method for accurately estimating an oxygen saturation metric for a volume of blood by an optical sensor measurement, comprising:

deploying a dual wavelength optical sensor into fluid communication with a volume of blood, wherein said volume of blood is characterized by a blood flow rate condition, said flow rate condition comprising one of;

relatively low, stasis, substantially stagnant;

determining a tissue overgrowth correction factor (K) for a first and a second wavelength of optical radiation in the dual wavelength optical sensor, wherein said first wavelength of optical radiation is substantially proportional to an amount of saturated oxygen present in said volume of blood and said second wavelength of radiation is substantially independent of the amount of saturated oxygen present in the volume of blood;

determining a nominal time interval for detecting the second wavelength of optical radiation (T2) after it is directed to a volume of blood having known optical properties;

determining a pair of calibration constants (A,B) for said first and said second wavelength of optical radiation;

measuring a first time interval for the first wavelength of radiation and a second time interval for the second wavelength of radiation when said first and second wavelengths of radiation are directed to the volume of blood; and

calculating a saturation metric for the saturated oxygen based upon the tissue overgrowth correction factor (K), the pair of calibration constants (A,B), the nominal time interval, the first time interval and the second time interval.

2. A method according to claim 1, wherein the calculating step further comprises:

calculating oxygen saturation (SAO₂ ) according to the following mathematical expression;

SAO₂=A+B{(K*T_R*T_IRnom)/((K*T_IR*T_IRnom)−

(T_R(T_IRnomT_IR)))}, wherein T_R is the first time interval, T_IR is the second time interval and T_IRnom is the nominal time interval.

3. A method according to claim 1, further comprising providing an oxygen saturation metric output signal.

4. A method according to claim 1, wherein after measuring the first time interval and the second time interval, performing the step of:

detecting a tissue overgrowth condition, and if the tissue overgrowth condition is positive then;

calculating a corrected oxygen saturation metric; and

if the tissue overgrowth condition is negative then;

calculating an uncorrected oxygen saturation metric.

5. A method according to claim 1, wherein the first wavelength of optical radiation is approximately 660 nm and the second wavelength of radiation is approximately 880 nm.

6. A method according to claim 1, wherein the dual wavelength optical sensor is disposed in a volume of blood proximate an implantable medical device.

7. A method according to claim 6, wherein the implantable medical device comprises:

an implantable heart monitor, a pacemaker, a cardioverter-defibrillator, a myostimulation device, a nerve stimulation device, a drug delivery device.

8. A method according to claim 1, wherein said dual wavelength optical sensor mechanically couples to an implantable medical device.

9. A method according to claim 1, wherein the oxygen saturation metric comprises a saturated arterial oxygen metric.

10. A system for accurately estimating an oxygen saturation metric for a volume of blood, comprising:

means for determining a tissue overgrowth correction factor (K) for a first and a second wavelength of optical radiation in a dual wavelength optical sensor, wherein said first wavelength of optical radiation is substantially proportional to saturated oxygen present in a volume of blood and said second wavelength of radiation is substantially independent of saturated oxygen;

means for determining a nominal time interval for detecting the second wavelength of optical radiation (T2) after it is directed to the volume of blood having known optical properties;

means for determining a pair of calibration constants (A,B) for said first and said second wavelength of optical radiation;

means for placing the dual wavelength optical sensor in the volume of blood, wherein said volume of blood is characterized by a blood flow-rate condition, said flow-rate condition comprising one of;

relatively low, stasis, substantially stagnant;

means for measuring a first time interval for the first wavelength of radiation and a second time interval for the second wavelength of radiation when said first and second wavelengths of radiation are directed to the volume of blood; and

means for calculating a saturation metric for a metabolite of interest based upon the tissue overgrowth correction factor (K), the pair of calibration constants (A,B), the nominal time interval, the first time interval and the second time interval.

11. A system according to claim 10, further comprising means for calculating oxygen saturation SAO₂ for the volume of blood according to the following mathematical expression:

SAO₂=A+B{(K*T_R*T_IRnom)/((K*T_IR*T_IRnom)−

(T_R(T_IRnom−

T_IR)))}, wherein T_R is the first time interval, T_IR is the second time interval and T_IRnom is the nominal time interval.

12. A system according to claim 10, further comprising providing an oxygen saturation-metric output signal.

13. A system according to claim 10, further comprising:

means for detecting a tissue overgrowth condition, and wherein if the tissue overgrowth condition is positive then calculating a corrected oxygen saturation metric; and

wherein if the tissue overgrowth condition is negative then calculating an uncorrected oxygen saturation metric.

14. A system according to claim 10, wherein the first wavelength of optical radiation is approximately 660 nm and the second wavelength of radiation is approximately 880 nm.

15. A system according to claim 10, wherein the dual wavelength optical sensor is configured to be disposed in the volume of blood proximate an implantable medical device.

16. A system according to claim 15, wherein the implantable medical device comprises one of:

an implantable heart monitor, a pacemaker, a cardioverter-defibrillator, a myostimulation device, a nerve stimulation device, a drug delivery device.

17. A system according to claim 10, wherein said dual wavelength optical sensor mechanically couples to an implantable medical device.

18. A system according to claim 10, wherein the oxygen saturation comprises an arterial oxygen saturation metric.